DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,117 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $6,283,840 | +16.0% | 25,260 | +7.9% | 0.51% | +16.6% |
Q4 2023 | $5,415,025 | -17.9% | 23,407 | -12.0% | 0.44% | -35.0% |
Q3 2023 | $6,597,530 | +27.9% | 26,592 | +23.7% | 0.67% | +57.8% |
Q2 2023 | $5,159,066 | +112.4% | 21,496 | +123.0% | 0.42% | +72.4% |
Q1 2023 | $2,429,183 | -5.7% | 9,638 | -0.7% | 0.25% | +7.9% |
Q4 2022 | $2,576,176 | +0.6% | 9,706 | -2.2% | 0.23% | -6.6% |
Q3 2022 | $2,562,000 | +0.3% | 9,921 | -0.8% | 0.24% | +3.4% |
Q2 2022 | $2,554,000 | -11.6% | 9,998 | +1.5% | 0.24% | +6.3% |
Q1 2022 | $2,889,000 | -4.4% | 9,848 | +7.2% | 0.22% | -7.1% |
Q4 2021 | $3,022,000 | +13.0% | 9,184 | +4.5% | 0.24% | -1.6% |
Q3 2021 | $2,675,000 | +14.0% | 8,785 | +0.5% | 0.24% | +11.5% |
Q2 2021 | $2,346,000 | +17.9% | 8,741 | -1.1% | 0.22% | +10.1% |
Q1 2021 | $1,990,000 | +2.4% | 8,841 | +1.1% | 0.20% | -10.8% |
Q4 2020 | $1,943,000 | +25.0% | 8,746 | -0.5% | 0.22% | +1.8% |
Q2 2020 | $1,555,000 | +28.1% | 8,791 | +0.3% | 0.22% | +560.6% |
Q1 2020 | $1,214,000 | -23.1% | 8,768 | -14.7% | 0.03% | -87.9% |
Q4 2019 | $1,579,000 | +10.0% | 10,285 | +3.5% | 0.27% | +1.5% |
Q3 2019 | $1,435,000 | +5.0% | 9,935 | +3.8% | 0.27% | -1.1% |
Q2 2019 | $1,367,000 | +16.7% | 9,568 | +7.9% | 0.27% | +7.5% |
Q1 2019 | $1,171,000 | +28.0% | 8,869 | 0.0% | 0.25% | +7.7% |
Q4 2018 | $915,000 | -5.1% | 8,869 | 0.0% | 0.24% | +8.3% |
Q3 2018 | $964,000 | +10.2% | 8,869 | +0.0% | 0.22% | +4.8% |
Q2 2018 | $875,000 | +0.9% | 8,868 | +0.1% | 0.21% | -5.5% |
Q1 2018 | $867,000 | +5.0% | 8,859 | -0.5% | 0.22% | +4.8% |
Q4 2017 | $826,000 | +8.1% | 8,902 | 0.0% | 0.21% | +5.0% |
Q3 2017 | $764,000 | +1.9% | 8,902 | +0.1% | 0.20% | +53.1% |
Q2 2017 | $750,000 | -1.4% | 8,889 | -0.1% | 0.13% | -44.0% |
Q1 2017 | $761,000 | +10.0% | 8,902 | +0.1% | 0.23% | +0.9% |
Q4 2016 | $692,000 | +3.3% | 8,889 | +3.9% | 0.23% | +351.0% |
Q3 2016 | $670,000 | -22.3% | 8,552 | +0.2% | 0.05% | -85.0% |
Q2 2016 | $862,000 | +3.9% | 8,539 | -2.4% | 0.34% | +3.0% |
Q1 2016 | $830,000 | +2.2% | 8,746 | -0.0% | 0.33% | -0.6% |
Q4 2015 | $812,000 | +7.0% | 8,747 | -2.8% | 0.33% | -47.5% |
Q3 2015 | $759,000 | -0.4% | 9,000 | 0.0% | 0.63% | +97.5% |
Q2 2015 | $762,000 | +0.8% | 9,000 | +1.1% | 0.32% | -1.2% |
Q1 2015 | $756,000 | -0.9% | 8,902 | 0.0% | 0.32% | -3.0% |
Q4 2014 | $763,000 | +2.7% | 8,902 | -9.0% | 0.33% | +25.7% |
Q3 2014 | $743,000 | -0.1% | 9,785 | +3.5% | 0.26% | +14.7% |
Q2 2014 | $744,000 | +0.1% | 9,450 | -4.6% | 0.23% | -9.8% |
Q1 2014 | $743,000 | +14.0% | 9,910 | +17.3% | 0.26% | -26.0% |
Q4 2013 | $652,000 | 0.0% | 8,446 | -10.3% | 0.35% | +9.1% |
Q3 2013 | $652,000 | 0.0% | 9,411 | -8.7% | 0.32% | -3.9% |
Q2 2013 | $652,000 | 0.0% | 10,306 | -1.8% | 0.33% | +3.1% |
Q1 2013 | $652,000 | -2.8% | 10,496 | -12.5% | 0.32% | +12.7% |
Q4 2012 | $671,000 | 0.0% | 12,001 | -1.3% | 0.28% | +0.7% |
Q3 2012 | $671,000 | +0.1% | 12,164 | -5.4% | 0.28% | -9.0% |
Q2 2012 | $670,000 | – | 12,862 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |